01

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Ritonavir

Brand Name : NORVIR

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 80mg/ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Product Web Link

Corporate PDF

02

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Ritonavir

Brand Name : NORVIR

Patent Number : 2178632

Filing Date : 1995-01-03

Strength per Unit : 80mg/ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Product Web Link

Corporate PDF

03

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Ritonavir

Brand Name : NORVIR

Patent Number : 2178632

Filing Date : 1995-01-03

Strength per Unit : 100mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Product Web Link

Corporate PDF

04

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Ritonavir

Brand Name : NORVIR SEC

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 100.0mg

Dosage Form : Soft Elastic Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Product Web Link

Corporate PDF

05

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Ritonavir

Brand Name : NORVIR SEC

Patent Number : 2178632

Filing Date : 1995-01-03

Strength per Unit : 100.0mg

Dosage Form : Soft Elastic Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-01-03

Date Granted : 2006-04-11

Product Web Link

Corporate PDF

06

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-11-12

Date Granted : 2005-06-28

Ritonavir

Brand Name : NORVIR SEC

Patent Number : 2271196

Filing Date : 1997-11-12

Strength per Unit : 100.0mg

Dosage Form : Soft Elastic Capsules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-11-12

Date Granted : 2005-06-28

Product Web Link

Corporate PDF

07

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-16

Date Granted : 1996-08-27

Ritonavir

Brand Name : NORVIR

Patent Number : 2135890

Filing Date : 1993-12-16

Strength per Unit : 80mg/ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-16

Date Granted : 1996-08-27

Product Web Link

Corporate PDF

08

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Ritonavir

Brand Name : NORVIR

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 100 mg

Dosage Form : Film coated tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Product Web Link

Corporate PDF

09

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-16

Date Granted : 1996-08-27

Ritonavir

Brand Name : NORVIR

Patent Number : 2135890

Filing Date : 1993-12-16

Strength per Unit : 100 mg

Dosage Form : Film coated tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-16

Date Granted : 1996-08-27

Product Web Link

Corporate PDF

10

AbbVie Corporation

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-11-10

Date Granted : 2009-07-14

Ritonavir

Brand Name : NORVIR

Patent Number : 2390092

Filing Date : 2000-11-10

Strength per Unit : 100 mg

Dosage Form : Film coated tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-11-10

Date Granted : 2009-07-14

Product Web Link

Corporate PDF

Ritonavir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

24 USDMF

11 CEP/COS

9 EU WC

3 KDMF

10 NDC API

22 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

62 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers

41 FDA Orange Book

18 Europe

7 Canada

1 Australia

25 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG;25MG

TABLET;ORAL - 200MG;50MG

TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

1 Minakem

3 Rochem International Inc

1 SPI Pharma

1 Seqens

8 DKSH

2 Jai Radhe Sales

1 PMC Isochem

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

5 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

4 ACG Worldwide

7 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 Bioplus Life Sciences

1 Clariant

12 Corel Pharma Chem

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

6 Ideal Cures Pvt Ltd

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

4 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

3 Roquette

15 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

2 Valens Pharmachem

TABLET;ORAL - 12.5MG;75MG;50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons